MedPath

Effects of Highly Absorptive Curcumin (curcured) on knee osteoarthritis for three months

Phase 3
Conditions
knee osteoarthritis
knee joint medial type
D020370
Registration Number
JPRN-jRCTs051200058
Lead Sponsor
Yamada Shigeru
Brief Summary

Curcured has succeeded in proofing a potential for treating human knee OA, particularly at an early stage.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

1)Medial knee osteoarthritis and KL classification II or III, 2) over 40 years. 3) consent of patient , 4) outpatient

Exclusion Criteria

1)Severe renal dysfunction or dialysis 2)severe liver dysfunction or liver cirrhosis 3)severe cardiovascular diseases 4)severe cerebrovascular dysfunction 5)severe diabetes mellitus 6)curcumin abuse patients 7)previous knee surgery or intraarticular injection for experimental period or steroid intraarticular injection before 2 months or steroid oral intake before 4 weeks 8)patient who must be excluded by the scientific responsible doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath